4//SEC Filing
CTI BIOPHARMA CORP 4
Accession 0000899243-17-006601
CIK 0000891293operating
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 4:59 PM ET
Size
5.6 KB
Accession
0000899243-17-006601
Insider Transaction Report
Form 4
Plunkett Matthew
EVP, Corporate Development
Transactions
- Award
Employee Stock Option (Right to Buy)
2017-03-01+60,000→ 60,000 totalExercise: $4.33Exp: 2027-02-28→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The option is scheduled to vest in six semi-annual installments over the three-year period following the grant date, subject to the reporting person's continued employment or service with the issuer through the applicable vesting date.
Documents
Issuer
CTI BIOPHARMA CORP
CIK 0000891293
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000891293
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 4:59 PM ET
- Size
- 5.6 KB